Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Pacira BioSciences, Inc.
PCRX
Litigation matter
Litigation matter at other companies
STERIS
STE
$0
-100%
Douglas Elliman
DOUG
$0
—
Franklin Electric
FELE
$0
—
Altria Group
MO
$785M
-1.8%
Cigna
CI
$0
—
Medtronic
MDT
$28.25M
-64.4%
Segments
By segment
See full
Reportable Segment
$0
-100%
Other financials
Income statement
See full
Revenue
$177.4M
+5.0%
Gross profit
$141.0M
+4.7%
Operating income
$6.9M
+247%
Net income
$2.9M
-39.4%
EPS (diluted)
$0.07
-30.0%
Balance sheet
See full
Cash & equivalents
$144.3M
-49.1%
Total debt
$411.2M
+15.3%
Total equity
$653.9M
-18.1%
Total assets
$1.2B
-23.8%
Cash flow
See full
Operating cash flow
$25.7M
-27.6%
CapEx
$2.7M
-68.1%
Free cash flow
$23.0M
-14.7%
Valuation
See full
Market cap
$997.34M
-11.9%
Enterprise value
$1.26B
+6.9%
P/E
194.1×
—
P/S
1.4×
-0.2×
Profitability
See full
Gross margin
79.3%
+1.7pp
Operating margin
3.3%
—
Net margin
0.7%
—
FCF margin
18.1%
-4.6pp
Returns & leverage
See full
Return on equity
0.7%
—
Debt / equity
0.6×
+0.2×
Current ratio
4.7×
+2.3×
Watchlist
Screener
Filings
Earnings
Charts